15.05.2014 Views

MALE GENITAL SYSTEM - Pathology

MALE GENITAL SYSTEM - Pathology

MALE GENITAL SYSTEM - Pathology

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

<strong>MALE</strong> <strong>GENITAL</strong> <strong>SYSTEM</strong><br />

• PENIS<br />

• SCROTUM, TESTIS, & EPIDIDYMIS<br />

• PROSTATE<br />

KUMAR, COTRAN, AND ROBBINS<br />

CH 18


PENIS<br />

• MALFORMATIONS<br />

• INFLAMMATORY LESIONS<br />

• NEOPLASMS


MALFORMATIONS OF THE PENIS<br />

ABNORMAL LOCATION OF URETHRAL ORIFICE<br />

ALONG PENILE SHAFT<br />

– HYPOSPADIAS (VENTRAL ASPECT)<br />

• MOST COMMON (1/300 LIVE <strong>MALE</strong> BIRTHS)<br />

– EPISPADIAS (DORSAL ASPECT)<br />

– MAY BE ASSOCIATED WITH OTHER <strong>GENITAL</strong><br />

ABNORMALITIES<br />

• INGUINAL HERNIAS<br />

• UNDESCENDED TESTES<br />

– CLINICAL CONSEQUENCES<br />

• CONSTRICTION OF ORIFICE<br />

• URINARY TRACT OBSTRUCTION<br />

• URINARY TRACT INFECTION<br />

• IMPAIRED REPRODUCTIVE FUNCTION


INFLAMMATORY LESIONS<br />

OF THE PENIS<br />

• SEXUALLY TRANSMITTED DISEASES<br />

• BALANITIS (BALANOPOSTHITIS)<br />

– INFLAMMATION OF THE GLANS (PLUS<br />

PREPUCE)<br />

– ASSOCIATED WITH POOR LOCAL<br />

HYGIENE IN UNCIRCUMCISED MEN<br />

• SMEGMA<br />

– DISTAL PENIS IS RED, SWOLLEN,<br />

TENDER<br />

• +/- PURULENT DISCHARGE


INFLAMMATORY LESIONS<br />

OF THE PENIS<br />

• PHIMOSIS<br />

– PREPUCE CANNOT BE EASILY<br />

RETRACTED OVER GLANS<br />

– MAY BE CON<strong>GENITAL</strong><br />

– USUALLY ASSOCIATED WITH<br />

BALANOPOSTHITIS AND<br />

SCARRING<br />

– PARAPHIMOSIS (TRAPPED GLANS)<br />

• URETHRAL CONSTRICTION


INFLAMMATORY LESIONS<br />

OF THE PENIS<br />

• FUNGAL INFECTIONS<br />

–CANDIDIASIS<br />

• ESPECIALLY IN DIABETICS<br />

• EROSIVE, PAINFUL, PRURITIC<br />

• CAN INVOLVE ENTIRE <strong>MALE</strong><br />

EXTERNAL <strong>GENITAL</strong>IA


NEOPLASMS OF THE PENIS<br />

• SQUAMOUS CELL CARCINOMA (SCC)<br />

– EPIDEMIOLOGY<br />

• UNCOMMON - ABOUT 1 % OF CA IN US MEN<br />

• UNCIRCUMCISED MEN BETWEEN 40 AND 70<br />

– PATHOGENESIS<br />

• POOR HYGIENE, SMEGMA<br />

• HUMAN PAPILLOMA VIRUS (16 AND 18)<br />

• CIS FIRST, THEN PROGRESSION TO<br />

INVASIVE SQUAMOUS CELL CARCINOMA


SCC OF THE PENIS<br />

• CLINICAL COURSE<br />

– USUALLY INDOLENT<br />

– LOCALLY INVASIVE<br />

– HAS SPREAD TO INGUINAL LYMPH NODES<br />

IN 25% OF CASES AT PRESENTATION<br />

– DISTANT METS RARE<br />

– 5 YR SURVIVAL<br />

• 70% WITHOUT LN METS<br />

• 27% WITH LN METS


LESIONS INVOLVING THE<br />

SCROTUM<br />

• INFLAMMATION<br />

– TINEA CRURIS (JOCK ITCH)<br />

• SUPERFICIAL DERMATOPHYTE INFECTION<br />

• SCALY, RED, ANNULAR PLAQUES, PRURITIC<br />

• INGUINAL CREASE TO UPPER THIGH<br />

• SQUAMOUS CELL CARCINOMA<br />

– HISTORICAL SIGNIFICANCE<br />

– SIR PERCIVAL POTT, 18TH CENTURY ENGLISH<br />

PHYSICIAN<br />

– CHIMNEY SWEEPS


LESIONS INVOLVING THE<br />

SCROTUM<br />

• SCROTAL ENLARGEMENT<br />

– HYDROCELE - MOST COMMON CAUSE<br />

• ACCUMULATION OF SEROUS FLUID WITHIN<br />

TUNICA VAGINALIS<br />

• INFECTIONS, TUMOR, IDIOPATHIC<br />

– HEMATOCELE<br />

– CHYLOCELE<br />

• FILIARIASIS - ELEPHANTIASIS<br />

– TESTICULAR DISEASE


LESIONS OF THE TESTES<br />

• CON<strong>GENITAL</strong><br />

• INFLAMMATORY<br />

• NEOPLASTIC


CRYPTORCHIDISM AND<br />

TESTICULAR ATROPHY<br />

• FAILURE OF TESTICULAR DESCENT<br />

• EPIDEMIOLOGY<br />

– ABOUT 1% OF <strong>MALE</strong>S<br />

– RIGHT > LEFT, 25% BILATERAL<br />

• PATHOGENESIS<br />

– HORMONAL ABNORMALITIES<br />

– TESTICULAR ABNORMALITIES<br />

– MECHANICAL PROBLEMS


CRYPTORCHIDISM AND<br />

TESTICULAR ATROPHY<br />

• CLINICAL COURSE<br />

– WHEN UNILATERAL, MAY SEE ATROPHY IN<br />

CONTRALATERAL TESTIS<br />

– STERILITY<br />

– INCREASED RISK OF MALIGNANCY (10X)<br />

– ORCHIOPEXY<br />

• MAY HELP PREVENT ATROPHY<br />

• DOES NOT DECREASE RISK OF MALIGNANCY


OTHER CAUSES OF<br />

TESTICULAR ATROPHY<br />

• CHRONIC ISCHEMIA<br />

• INFLAMMATION OR TRAUMA<br />

• HYPOPITUITARISM<br />

• EXCESS FE<strong>MALE</strong> SEX HORMONES<br />

– THERAPEUTIC ADMINISTRATION<br />

– CIRRHOSIS<br />

• MALNUTRITION<br />

• IRRADIATION<br />

• CHEMOTHERAPY


INFLAMMATORY LESIONS<br />

OF THE TESTIS<br />

• USUALLY INVOLVE THE EPIDIDYMIS<br />

FIRST<br />

• SEXUALLY TRANSMITTED DISEASES<br />

• NONSPECIFIC EPIDIDYMITIS AND<br />

ORCHITIS<br />

– SECONDARY TO UTI<br />

• BACTERIAL AND NON-BACTERIAL<br />

– SWELLING, TENDERNESS<br />

– ACUTE INFLAMMATORY INFILTRATE


INFLAMMATORY LESIONS OF<br />

THE TESTIS<br />

• MUMPS<br />

– 20% OF ADULT <strong>MALE</strong>S WITH MUMPS<br />

– EDEMA AND CONGESTION<br />

– CHRONIC INFLAMMATORY INFILTRATE<br />

– MAY CAUSE ATROPHY AND STERILITY<br />

• TUBERCULOSIS<br />

– GRANULOMATOUS INFLAMMATION<br />

– CASEOUS NECROSIS<br />

• AUTOIMMUNE GRANULOMATOUS<br />

ORCHITIS<br />

– RARE FINDING IN MIDDLE AGED MEN


TESTICULAR NEOPLASMS<br />

• EPIDEMIOLOGY<br />

– MOST IMPORTANT CAUSE OF PAINLESS<br />

ENLARGEMENT OF TESTIS<br />

– 6/100,000 <strong>MALE</strong>S, WHITES > BLACKS (US)<br />

– INCREASED FREQUENCY IN SIBLINGS<br />

– PEAK INCIDENCE 15-34 YRS<br />

– MOST ARE MALIGNANT<br />

– ASSOCIATED WITH GERM CELL<br />

MALDEVELOPMENT<br />

• CRYPTORCHIDISM<br />

• TESTICULAR DYSGENESIS(XXY)


TESTICULAR NEOPLASMS<br />

• PATHOGENESIS<br />

– 95% ARISE FROM GERM CELLS<br />

• ISOCHROMOSOME 12, i(12p), IS A COMMON<br />

FINDING<br />

– RARELY ARISE FROM SERTOLI CELLS<br />

OR LEYDIG CELLS<br />

• THESE ARE OFTEN BENIGN<br />

– Lymphoma<br />

• men > 60 yo


WHO CLASSIFICATION OF<br />

TESTICULAR TUMORS<br />

• ONE HISTOLOGIC PATTERN (40%)<br />

– SEMINOMAS (30%)<br />

– EMBRYONAL CARCINOMA<br />

– YOLK SAC TUMOR<br />

– CHORIOCARCINOMA<br />

– TERATOMA<br />

• MULTIPLE HISTOLOGIC PATTERNS (60%)<br />

– EMBRYONAL CA + TERATOMA<br />

– CHORIOCARCINOMA + OTHER<br />

– OTHER COMBINATIONS


HISTOGENESIS OF TESTICULAR<br />

NEOPLASMS (PEAK INCIDENCE)<br />

GERM CELL PRECURSOR<br />

GONADAL<br />

DIFFERENTIATION<br />

TOTIPOTENTIAL<br />

DIFFERENTIATION<br />

(NONSEMINOMA)<br />

SEMINOMA<br />

(40-50 Y)<br />

TROPHOBLASTIC<br />

DIFFERENTIATION<br />

EMBRYONAL CA<br />

(UNDIFFERENTIATED)<br />

(20-30 Y)<br />

YOLK SAC<br />

DIFF<br />

SOMATIC<br />

DIFFERENTIATION<br />

TERATOMA<br />

(20-30 Y)<br />

CHORIOCARCINOMA<br />

(20-30 Y)<br />

hCG +<br />

YOLK SAC TUMOR<br />

(< 3 Y)<br />

AFP +<br />

MATURE<br />

IMMATURE<br />

MALIGNANT TX


CLINICAL COURSE OF<br />

TESTICULAR TUMORS<br />

• USUALLY PRESENT WITH PAINLESS<br />

ENLARGEMENT OF TESTIS<br />

• MAY PRESENT WITH METASTASES<br />

– NONSEMINOMAS (MORE COMMON)<br />

• LYMPH NODES, LIVER AND LUNGS<br />

– SEMINOMAS<br />

• USUALLY JUST REGIONAL LYMPH NODES<br />

• TUMOR MARKERS (hCG AND AFP)<br />

• TREATMENT SUCCESS DEPENDS ON<br />

HISTOLOGY AND STAGE<br />

– SEMINOMAS VERY SENSITIVE TO BOTH<br />

RADIO- AND CHEMOTHERAPY


DISEASES OF THE<br />

PROSTATE<br />

• PROSTATITIS<br />

• NODULAR HYPERPLASIA<br />

• CANCER


PROSTATITIS<br />

• ACUTE BACTERIAL PROSTATITIS<br />

• CHRONIC BACTERIAL PROSTATITIS<br />

• CHRONIC ABACTERIAL PROSTATITIS


• ETIOLOGY<br />

ACUTE BACTERIAL<br />

PROSTATITIS<br />

– SAME ORGANISMS THAT CAUSE UTI<br />

• E coli, OTHER GNR<br />

• PATHOGENESIS<br />

– ORGANISMS ASCEND FROM URETHRA<br />

AND URINARY BLADDER<br />

– RARELY, HEMATOGENOUS SPREAD


ACUTE BACTERIAL<br />

PROSTATITIS<br />

• MORPHOLOGY<br />

– ACUTE INFLAMMATION, ESPECIALLY IN THE<br />

GLANDS, WITH MICROABSESSES<br />

– CONGESTION, EDEMA<br />

• CLINICAL COURSE<br />

– DYSURIA, FREQUENCY, LOW BACK PAIN,<br />

PELVIC PAIN<br />

– ENLARGED, EXQUISITELY TENDER<br />

– +/- FEVER OR LEUKOCYTOSIS<br />

– USUALLY RESOLVES WITH WITH AB RX


CHRONIC PROSTATITIS<br />

• ETIOLOGY<br />

– MAY FOLLOW ACUTE PROSTATITIS<br />

– MAY DEVELOP INSIDIOUSLY<br />

– CULTURE POSITIVE (BACTERIAL)<br />

• SAME ORGANISMS THAT CAUSE AP<br />

– CULTURE NEGATIVE (ABACTERIAL)<br />

• MAY BE RELATED TO<br />

– CHLAMYDIA TRACHOMATIS<br />

– UREAPLASMA UREALYTICUM<br />

• MOST COMMON FORM OF CP


CHRONIC PROSTATITIS<br />

• MORPHOLOGY<br />

– LYMPHOCYTIC INFILTRATE<br />

– NEUTROPHILS AND MACROPHAGES<br />

– SOME EVIDENCE OF TISSUE DESTRUCTION<br />

• CLINICAL COURSE<br />

– SIMILAR TO AP<br />

• LESS ACUTE SYMPTOMS<br />

• MORE RESISTANT TO AB RX<br />

– CBP OFTEN ASSOCIATED WITH RECURRENT<br />

UTI


PROLIFERATIVE LESIONS OF THE PROSTATE<br />

PERIURETHRAL<br />

AND<br />

TRANSITIONAL<br />

ZONES<br />

NORMAL PROSTATE<br />

URETHRA<br />

PERIPHERAL<br />

ZONE<br />

NODULAR HYPERPLASIA<br />

CARCINOMA


NODULAR HYPERPLASIA<br />

• OTHER TERMS USED<br />

– GLANDULAR AND STROMAL<br />

HYPERPLASIA<br />

– BENIGN PROSTATIC HYPERTROPHY<br />

(HYPERPLASIA)<br />

• EPIDEMIOLOGY<br />

– OCCURS IN 20% OF MEN OVER 40<br />

– OCCURS IN 90% OF MEN OVER 70


PATHOGENESIS OF<br />

NODULAR HYPERPLASIA<br />

• PROLIFERATION OF BOTH EPITHELIAL<br />

AND STROMAL ELEMENTS<br />

• BOTH ANDROGENS AND ESTROGENS MAY<br />

PLAY A ROLE<br />

– NOT SEEN IN <strong>MALE</strong>S CASTRATED BEFORE<br />

PUBERTY<br />

– INHIBITORS OF TESTOSTERONE METABOLISM<br />

USEFUL IN TREATMENT<br />

– RELATIVE INCREASE IN ESTROGENS IN OLDER<br />

MEN MAY INCREASE DHT RECEPTORS IN<br />

PROSTATE


CLINICAL COURSE OF<br />

NODULAR HYPERPLASIA<br />

• SYMPTOMS OCCUR IN ONLY 10% OF MEN<br />

WITH NODULAR HYPERPLASIA<br />

• HESITANCY<br />

• URINARY RETENTION<br />

– URGENCY, FREQUENCY, NOCTURIA, UTI<br />

• TREATMENT<br />

– MEDICAL<br />

– SURGICAL<br />

• COMMON CAUSE FOR ELEVATED<br />

PROSTATE SPECIFIC ANTIGEN (PSA)


CARCINOMA OF THE<br />

PROSTATE<br />

• EPIDEMIOLOGY<br />

– MOST COMMON VISCERAL CANCER<br />

• ABOUT 70/100,000 MEN IN US<br />

• 200,000 NEW CASES/YR IN US<br />

• 20% ARE LETHAL<br />

– SECOND MOST COMMON CAUSE OF CANCER<br />

DEATH IN MEN<br />

– PEAK INCIDENCE OF CLINICAL CANCER IS 65-<br />

75 YO<br />

– LATENT CA IS EVEN MORE PREVALENT<br />

• >50% IN MEN > 80 YO


CARCINOMA OF THE<br />

PROSTATE<br />

• PATHOGENESIS<br />

– HORMONAL FACTORS<br />

• DOES NOT OCCUR IN EUNUCHS<br />

• ORCHIECTOMY AND/OR ESTROGEN TREATMENT<br />

INHIBITS GROWTH<br />

– GENETIC FACTORS<br />

• INCREASED RISK IN FIRST ORDER RELATIVES<br />

• BLACKS > WHITES (SYMPTOMATIC CA)<br />

– ENVIRONMENTAL FACTORS<br />

• GEOGRAPHIC DIFFERENCES IN INCIDENCE OF<br />

CLINICAL CANCER (NOT OF LATENT CA)<br />

• CHANGE IN INCIDENCE WITH MIGRATION


CARCINOMA OF THE PROSTATE<br />

• CLINICAL COURSE<br />

– OFTEN CLINICALLY SILENT<br />

– DIGITAL RECTAL EXAM (DRE)<br />

– PROSTATE SPECIFIC ANTIGEN (PSA)<br />

• > 4 ng/ml IN PERIPHERAL BLOOD<br />

• FREE PSA < 25%<br />

– TRANSRECTAL ULTRASOUND<br />

– NEEDLE BIOPSY<br />

– PROSTATISM (LIKE BPH)<br />

– METASTASES<br />

• OSTEOBLASTIC<br />

– TREATMENT- SURGERY, RADIATION,<br />

HORMONES, CHEMO


• STAGING<br />

A<br />

B<br />

C<br />

D<br />

CARCINOMA OF THE<br />

MICROSCOPIC ONLY<br />

MACROSCOPIC (PALPABLE)<br />

EXTRACAPSULAR<br />

METASTATIC<br />

PROSTATE<br />

• PROGNOSIS DEPENDENT ON STAGE AND<br />

HISTOLOGIC GRADE<br />

– 90% 10 YR SURVIVAL FOR A AND B<br />

– 10-40% 10 YR SURVIVAL FOR C AND D

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!